Involvement of cAMP-Dependent Protein Kinase in the Nucleus Accumbens in Cocaine Versus Social Interaction Reward.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
31 Dec 2020
Historique:
received: 07 12 2020
revised: 24 12 2020
accepted: 28 12 2020
entrez: 5 1 2021
pubmed: 6 1 2021
medline: 26 3 2021
Statut: epublish

Résumé

Evidence suggests that PKA activity in the nucleus accumbens (NAc) plays an essential role in reward-related learning. In this study, we investigated whether PKA is differentially involved in the expression of learning produced by either natural reinforcers or psychostimulants. For that purpose, we inhibited PKA through a bilateral infusion of Rp-cAMPS, a specific PKA inhibitor, directly into the NAc. The effects of PKA inhibition in the NAc on the expression of concurrent conditioned place preference (CPP) for cocaine (drug) and social interaction (natural reward) in rats were evaluated. We found that PKA inhibition increased the expression of cocaine preference. This effect was not due to altered stress levels or decreased social reward. PKA inhibition did not affect the expression of natural reward as intra-NAc Rp-cAMPS infusion did not affect expression of social preference. When rats were trained to express cocaine or social interaction CPP and tested for eventual persisting preference 7 and 14 days after CPP expression, cocaine preference was persistent, but social preference was abolished after the first test. These results suggest that PKA in the NAc is involved in drug reward learning that might lead to addiction and that only drug, but not natural, reward is persistent.

Identifiants

pubmed: 33396297
pii: ijms22010345
doi: 10.3390/ijms22010345
pmc: PMC7794935
pii:
doi:

Substances chimiques

Central Nervous System Stimulants 0
Cyclic AMP E0399OZS9N
Cyclic AMP-Dependent Protein Kinases EC 2.7.11.11
Cocaine I5Y540LHVR

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Austrian Science Fund FWF
ID : M 2486
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : T 758
Pays : Austria

Références

Neuron. 2005 Sep 15;47(6):873-84
pubmed: 16157281
J Neurosci. 2018 Feb 21;38(8):1901-1914
pubmed: 29348192
Behav Brain Res. 2002 Dec 2;137(1-2):75-114
pubmed: 12445717
Neuropharmacology. 2011 Dec;61(7):1109-22
pubmed: 21459101
Eur Neuropsychopharmacol. 2020 Aug;37:12-28
pubmed: 32624295
Front Behav Neurosci. 2011 Nov 30;5:80
pubmed: 22232578
Front Behav Neurosci. 2014 Oct 17;8:363
pubmed: 25368560
Neurotox Res. 2004;6(1):91-104
pubmed: 15184110
Brain Res Brain Res Protoc. 2004 Aug;13(3):151-8
pubmed: 15296852
Nat Neurosci. 2018 Nov;21(11):1520-1529
pubmed: 30323276
Psychopharmacology (Berl). 2007 Jan;190(1):65-72
pubmed: 17047929
Eur J Neurosci. 2005 Sep;22(5):1214-20
pubmed: 16176364
Eur J Neurosci. 2016 May;43(9):1229-36
pubmed: 26970240
Psychopharmacology (Berl). 2003 Oct;170(1):23-32
pubmed: 12768275
Brain Res. 1991 May 10;548(1-2):100-10
pubmed: 1651140
Front Behav Neurosci. 2012 Sep 24;6:63
pubmed: 23015784
CNS Drugs. 2011 Apr;25(4):271-87
pubmed: 21425881
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17145-50
pubmed: 18955698
Physiol Behav. 2012 Feb 1;105(3):749-56
pubmed: 22008744
Psychopharmacology (Berl). 1988;94(2):221-6
pubmed: 3127848
Behav Pharmacol. 2000 Aug;11(5):365-76
pubmed: 11103888
Synapse. 2004 Mar 15;51(4):241-8
pubmed: 14696012
Neuron. 2004 Sep 30;44(1):161-79
pubmed: 15450168
Brain Res. 1997 Nov 14;775(1-2):30-6
pubmed: 9439825
Addict Biol. 2011 Apr;16(2):273-84
pubmed: 21309948
Addict Biol. 2021 Jan;26(1):e12878
pubmed: 31984611
Neuropsychopharmacology. 2006 Jul;31(7):1406-19
pubmed: 16192983
J Neurosci. 1998 Mar 1;18(5):1848-59
pubmed: 9465009
Biol Psychiatry. 2004 Jul 1;56(1):30-40
pubmed: 15219470
J Neurosci. 2005 May 18;25(20):5061-5
pubmed: 15901788
Brain Res. 1995 Mar 20;674(2):299-306
pubmed: 7796110
PLoS One. 2011;6(10):e26761
pubmed: 22046347
Genes Brain Behav. 2013 Aug;12(6):666-72
pubmed: 23790091
Mol Med Rep. 2020 Sep;22(3):2364-2372
pubmed: 32705202
Neurobiol Learn Mem. 2002 Jan;77(1):44-62
pubmed: 11749085
J Neurochem. 2003 Jun;85(6):1604-13
pubmed: 12787079
J Neurochem. 2001 Apr;77(2):542-9
pubmed: 11299316
Psychopharmacology (Berl). 2009 Dec;207(3):485-98
pubmed: 19798482
J Neurochem. 2005 Feb;92(3):536-45
pubmed: 15659224
J Neurosci. 2013 Feb 20;33(8):3434-42
pubmed: 23426671
Front Behav Neurosci. 2017 Nov 08;11:225
pubmed: 29167636
Eur J Pharmacol. 1996 Dec 27;318(1):31-5
pubmed: 9007509
Behav Pharmacol. 2010 Jul;21(4):323-31
pubmed: 20505511
Neurochem Res. 2016 Mar;41(3):492-9
pubmed: 26088685

Auteurs

Inês M Amaral (IM)

Division of Psychiatry I, Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University Innsbruck, 6020 Innsbruck, Austria.

Cristina Lemos (C)

Division of Psychiatry I, Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University Innsbruck, 6020 Innsbruck, Austria.

Isabella Cera (I)

Institute for Neuroscience, Medical University Innsbruck, 6020 Innsbruck, Austria.

Georg Dechant (G)

Institute for Neuroscience, Medical University Innsbruck, 6020 Innsbruck, Austria.

Alex Hofer (A)

Division of Psychiatry I, Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University Innsbruck, 6020 Innsbruck, Austria.

Rana El Rawas (R)

Division of Psychiatry I, Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University Innsbruck, 6020 Innsbruck, Austria.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH